Ford Kathleen's Insider Trades & SAST Disclosures
Ford Kathleen's most recent trade in Kura Oncology Inc was a trade of 1,817 Common Stock done at an average price of $7.9 . Disclosure was reported to the exchange on Jan. 28, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Ford Kathleen.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Kura Oncology Inc | Kathleen Ford | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 7.87 per share. | 28 Jan 2025 | 1,817 | 21,367 (0%) | 0% | 7.9 | 14,303 | Common Stock |
| Kura Oncology Inc | Kathleen Ford | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 185,000 | 185,000 | - | - | Option to purchase common stock | |
| Kura Oncology Inc | Kathleen Ford | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 16.03 per share. | 18 Nov 2024 | 526 | 23,184 (0%) | 0% | 16.0 | 8,434 | Common Stock |
| Kura Oncology Inc | Ford Kathleen | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 17.80 per share. | 29 Jan 2024 | 1,496 | 21,602 (0%) | 0% | 17.8 | 26,630 | Common Stock |
| Kura Oncology Inc | Ford Kathleen | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 185,000 | 185,000 | - | - | Option to purchase common stock | |
| Kura Oncology Inc | Kathleen Ford | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2023 | 185,000 | 185,000 | - | - | Option to purchase common stock | |
| Kura Oncology Inc | Kathleen Ford | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 13.89 per share. | 27 Jan 2023 | 1,821 | 21,214 (0%) | 0% | 13.9 | 25,294 | Common Stock |
| Kura Oncology Inc | Kathleen Ford | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2022 | 171,000 | 171,000 | - | - | Option to purchase common stock | |
| Kura Oncology Inc | Kathleen Ford | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2022 | 21,900 | 23,035 (0%) | 0% | 0 | Common Stock | |
| Kura Oncology Inc | Kathleen Ford | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 29.43 per share. | 15 Mar 2021 | 6,250 | 0 (0%) | 0% | 29.4 | 183,951 | Common Stock |
| Kura Oncology Inc | Kathleen Ford | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2021 | 6,250 | 215,625 | - | - | Option to purchase common stock | |
| Kura Oncology Inc | Kathleen Ford | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 19.43 per share. | 15 Mar 2021 | 6,250 | 6,250 (0%) | 0% | 19.4 | 121,438 | Common Stock |
| Kura Oncology Inc | Kathleen Ford | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2021 | 140,000 | 140,000 | - | - | Option to purchase common stock | |
| Kura Oncology Inc | Kathleen Ford | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2020 | 9,375 | 221,875 | - | - | Option to purchase common stock | |
| Kura Oncology Inc | Kathleen Ford | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 19.43 per share. | 15 Dec 2020 | 6,250 | 6,250 (0%) | 0% | 19.4 | 121,438 | Common Stock |
| Kura Oncology Inc | Kathleen Ford | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 40.60 per share. | 15 Dec 2020 | 6,250 | 0 (0%) | 0% | 40.6 | 253,781 | Common Stock |
| Kura Oncology Inc | Kathleen Ford | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 40.60 per share. | 15 Dec 2020 | 3,125 | 0 (0%) | 0% | 40.6 | 126,886 | Common Stock |
| Kura Oncology Inc | Kathleen Ford | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 19.43 per share. | 15 Dec 2020 | 3,125 | 3,125 (0%) | 0% | 19.4 | 60,719 | Common Stock |
| Kura Oncology Inc | Kathleen Ford | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 39.43 per share. | 10 Nov 2020 | 6,250 | 0 (0%) | 0% | 39.4 | 246,438 | Common Stock |
| Kura Oncology Inc | Kathleen Ford | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Nov 2020 | 6,250 | 231,250 | - | - | Option to purchase common stock | |
| Kura Oncology Inc | Kathleen Ford | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 19.43 per share. | 10 Nov 2020 | 6,250 | 6,250 (0%) | 0% | 19.4 | 121,438 | Common Stock |
| Kura Oncology Inc | Kathleen Ford | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 19.43 per share. | 14 Sep 2020 | 6,250 | 6,250 (0%) | 0% | 19.4 | 121,438 | Common Stock |
| Kura Oncology Inc | Kathleen Ford | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Sep 2020 | 6,250 | 237,500 | - | - | Option to purchase common stock | |
| Kura Oncology Inc | Kathleen Ford | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Sep 2020 | 6,250 | 243,750 | - | - | Option to purchase common stock | |
| Kura Oncology Inc | Kathleen Ford | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 29.43 per share. | 14 Sep 2020 | 6,250 | 0 (0%) | 0% | 29.4 | 183,938 | Common Stock |
| Kura Oncology Inc | Kathleen Ford | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 19.43 per share. | 14 Sep 2020 | 6,250 | 6,250 (0%) | 0% | 19.4 | 121,438 | Common Stock |
| Kura Oncology Inc | Kathleen Ford | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 29.43 per share. | 14 Sep 2020 | 6,250 | 0 (0%) | 0% | 29.4 | 183,938 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges